Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank94
3Y CAGR+42.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+42.1%/yr
Quarterly compound
Percentile
P94
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 111.50% |
| Q2 2025 | -621.61% |
| Q1 2025 | 123.26% |
| Q4 2024 | -424.62% |
| Q3 2024 | 59.77% |
| Q2 2024 | -1146.79% |
| Q1 2024 | 164.12% |
| Q4 2023 | 92.81% |
| Q3 2023 | -58.13% |
| Q2 2023 | 69.76% |
| Q1 2023 | 24.72% |
| Q4 2022 | 60.71% |
| Q3 2022 | 38.87% |
| Q2 2022 | -28.13% |
| Q1 2022 | 1.01% |
| Q4 2021 | 43.34% |
| Q3 2021 | 31.50% |
| Q2 2021 | -56.65% |
| Q1 2021 | 12.88% |
| Q4 2020 | -10.97% |
| Q3 2020 | -134.83% |
| Q2 2020 | -2.96% |
| Q1 2020 | -10.76% |
| Q4 2019 | 7.09% |
| Q3 2019 | 27.89% |
| Q2 2019 | -166.19% |
| Q1 2019 | 25.12% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 100.00% |
| Q1 2018 | -669.28% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 35.01% |
| Q4 2016 | 9.16% |
| Q3 2016 | 0.00% |